Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1

Overview of attention for article published in Gastroenterology, August 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 10 patents
wikipedia: 1 Wikipedia page

guideline: 3 clinical guideline sources

Readers on

mendeley: 70 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

ALISPORIVR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION

Application US-20150328280-A1

United States of America

19 Nov 2015

A NOVEL INTERFERON-λ4 (IFNL4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF

Application WO-2013148272-A1

World Intellectual Property Organisation (WIPO)

03 Oct 2013

A SINGLE NUCLEOTIDE POLYMORPHISM ON CHROMOSOME 15 THAT PREDICTS HCV TREATMENT RESPONSES

Application WO-2013079424-A1

World Intellectual Property Organisation (WIPO)

06 Jun 2013

Single nucleotide polymorphisms that predict HCV treatment outcomes

Application EP-2589670-A1

European Patent Office

08 May 2013

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.